Co-founder of StrainX Bioworks, a synthetic biology company.
Akshay Mittal is Co-founder of StrainX Bioworks, a synthetic biology company. StrainX Bioworks's most recent disclosed round was a Funding round of $13M in May 2026.
StrainX Bioworks is a synthetic biology startup scaling precision fermentation — commercial fermentation capacity, bioprocess engineering and global commercialization of bio-based products.
Akshay Mittal is a Co-founder of StrainX Bioworks, a synthetic biology company.
StrainX Bioworks's founders and leadership on record at StartupFox are Akshay Mittal, Alok Malviya and Brij Bhushan.
StrainX Bioworks has raised $13M across 1 disclosed round on record. The latest was a Funding round of $13M in May 2026, with PrimeVP & Leo Capital (co-leads), Good Startup, Sparrow Capital.
StartupFox has published 1 story naming Akshay Mittal; the most recent is “StrainX Bioworks Raises $13M Led by PrimeVP and Leo Capital”.
This profile is compiled by the StartupFox desk from company announcements, regulatory filings and our own reporting. If this is you, you can verify it with LinkedIn and edit it.
